The AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship Program is designed to encourage exceptional clinical research by bridging close collaboration between academia and industry. Fellows have the opportunity to gain experience in early-stage and/or late-stage clinical development at the facilities of AstraZeneca in Gaithersburg, Maryland. 

2024 Grantee

Biography

Dr. Zheng has a background in molecular oncology from the Spanish National Cancer Research Centre and completed his internal medicine training at Mount Sinai West-Morningside and Memorial Sloan Kettering Cancer Center. He is currently a hematology/oncology fellow at the Mayo Clinic in Arizona. He has played critical roles in a number of clinical trials and has participated in the ASCO/AACR Clinical Trial Workshop, consequently solidifying his interest in trial development. His research is driven by a passion for advancing therapy development for gastrointestinal tumors. His ongoing efforts aim to bridge the gap between academia and industry, ensuring innovative and effective cancer treatments.

Acknowledgment of Support

“I am incredibly grateful to receive the AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship, which provides an unparalleled opportunity to gain hands-on experience in drug development and biomarker research. This program will significantly enhance my skills and knowledge, allowing me to contribute more effectively to the field of gastrointestinal oncology and advance my career as a clinical trialist.”

2023 Grantee

Biography

Dr. Sone received his medical degree at the Nagoya City University in Nagoya, Japan, before completing a residency and a fellowship in respiratory medicine at Kainan Hospital, Japan. He then completed his doctorate at Nagoya City University Graduate School of Medicine, followed by a postdoctoral research year at Nagoya University. He currently works as a postdoctoral fellow at the Icahn School of Medicine at Mount Sinai in New York, where he aims to interrogate HPV-specific immune responses in patients with head and neck cancers.

Acknowledgement of Support

“I am grateful and honored to be awarded the AACR-AstraZeneca Clinical Immuno-oncology Research Training Fellowship. This fellowship will provide me with further training opportunities in drug development from a different perspective and will be invaluable for my career development as a physician-scientist in the field of immuno-oncology.”